ACTIVE CLINICAL TRIAL
COPD
This study is for adults 40 to 80 years old, who have COPD and are at high risk for cardiovascular disease, or have experienced a heart event. This study is comparing how two medications may help to prevent COPD flare-ups and serious heart events in people with COPD.
Participation is expected to last for three years with 13 total study visits.
Participant Eligibility
-
Are you between the age of 40 and 80 years old?
-
Have you been diagnosed with COPD?
-
Are you potentially at high risk for heart disease or have you experienced a heart event such as a heart attack?
-
You're NOT currently taking an inhaled steroid.
​
If the answer is YES, please fill out the form and a Kalo Team member will contact you promptly. ​​
Privacy & Disclaimer
Participation is voluntary and at no cost. You may withdraw at any time. Your information will be used only to contact you about research opportunities and will not be sold or shared. Compensation may be available for eligible participants.